PLLBA-01 PEMBROLIZUMAB (PEMBRO) VS PLACEBO AS POST NEPHRECTOMY ADJUVANT THERAPY FOR PATIENTS (pts) WITH RENAL CELL CARCINOMA (RCC): RANDOMIZED, DOUBLE-BLIND, PHASE 3 KEYNOTE-564 STUDY

Saved in:
Bibliographic Details
Published inThe Journal of urology Vol. 206; no. Supplement 3
Main Authors Choueiri, Toni, Tomczak, Piotr, Park, Se Hoon, Venugopal, Balaji, Ferguson, Thomas, Chang, Yen-Hwa, Hajek, Jaroslav, Symeonides, Stefan N., Lee, Jae Lyun, Sarwar, Naveed, Thiery-Vuillemin, Antoine, Gross-Goupil, Marine, Mahave, Mauricio, Haas, Naomi, Sawrycki, Piotr, Zhang, Pingye, Imai, Kentaro, Willemann-Rogerio, Jaqueline, Quinn, David, Powles, Thomas
Format Journal Article
LanguageEnglish
Published 01.09.2021
Online AccessGet full text

Cover

More Information
ISSN:0022-5347
1527-3792
DOI:10.1097/JU.0000000000002150.01